Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,656,255

« Back to Dashboard

Summary for Patent: 5,656,255

Title: Composition to help stop smoking
Abstract:A composition for administration to the nasal mucosa of a subject comprises a solution of nicotine or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable solvent. The composition has a nicotine concentration in the range of about 10 to about 40 mg/ml and contains a suitable agent to produce a viscosity in the range of about 1 to about 30 centipoise. The composition assists in reduction of the desire of the subject to smoke tobacco or provides a substitute for tobacco smoking.
Inventor(s): Jones; Richard L. (Edmonton, CA)
Assignee: Pharmacia & Upjohn AB (SE)
Application Number:08/256,312
Patent Claim Types:
see list of patent claims
Formulation; Compound; Delivery; Device; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,656,255

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9200047Jan 03, 1992
PCT Information
PCT FiledJanuary 04, 1993PCT Application Number:PCT/CA93/00003
PCT Publication Date:July 08, 1993PCT Publication Number: WO93/12764

International Patent Family for Patent: 5,656,255

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria182070► Subscribe
Australia3340393► Subscribe
Australia664415► Subscribe
Canada2127253► Subscribe
Czech Republic294555► Subscribe
Czech Republic9401608► Subscribe
Germany69325643► Subscribe
Denmark0619729► Subscribe
European Patent Office0619729► Subscribe
Spain2135460► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Argus Health
Farmers Insurance
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: